StockNews.AI
ABBV
StockNews.AI
28 days

BOTOX® Cosmetic (onabotulinumtoxinA) Selects This Year's Entrepreneurs for The Confidence Project

1. AbbVie launches 'The Confidence Project' for women entrepreneurs. 2. Participants access coaching, mentorship, and $20,000 grants. 3. Focus on closing the Confidence Gap and accelerating growth. 4. The project aligns with ABBV's aesthetic brand BOTOX® Cosmetic. 5. 20 grant winners will be announced in October 2025.

12m saved
Insight
Article

FAQ

Why Bullish?

Supporting women entrepreneurs strengthens ABBV's branding in aesthetics, potentially boosting BOTOX® sales. Historical examples show similar initiatives lead to improved market perception.

How important is it?

The connection to women's entrepreneurship can enhance ABBV's social responsibility image, potentially attracting investors and customers interested in corporate ethics.

Why Long Term?

The initiative promotes brand loyalty and growth which can pay off over several years. Investing in community-focused programs often results in long-term brand value.

Related Companies

BOTOX
Select Business Owners Will Receive Access to Coaching, Mentorship, and Community During Exclusive 12-Week Virtual "Boostcamp" Additionally, 20 Entrepreneurs Will Each Receive a $20,000 Grant from BOTOX® Cosmetic , /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the 2025 class of entrepreneurs who will participate in The Confidence Project: Empowering Women Entrepreneurs. This initiative, led by BOTOX® Cosmetic, is aimed at closing the Confidence Gap and accelerating business growth for select entrepreneurs from across the country. Meet the Entrepreneurs: Introducing The Confidence Project’s 2025 Class BOTOX® Cosmetic (onabotulinumtoxinA) Selects This Year’s Entrepreneurs for The Confidence Project This year's participants were selected from a pool of applicants representing a wide range of industries, backgrounds, and business ideas. BOTOX® Cosmetic invited these business owners to participate in a Virtual Community Summit earlier this month centered around business development, camaraderie, and financial coaching. Following the summit, each entrepreneur is set to begin an intensive "Boostcamp" powered by Hello Alice, an online platform that helps businesses launch and grow. The Boostcamp is designed to provide business owners with practical tools, mentorship, and education to help them scale their venture with confidence. "On behalf of BOTOX® Cosmetic and everyone at Allergan Aesthetics, I am proud to welcome this new group of entrepreneurs to The Confidence Project," said Nicole Katz, Vice President, Customer Engagement and Corporate Affairs at Allergan Aesthetics. "As the leader in aesthetics, we know what's possible when preparation and confidence are met with opportunity. We are honored to support this year's class of entrepreneurs. BOTOX® Cosmetic is committed to building a future where women entrepreneurs have resources to forge new paths and propel their businesses to success." Following the Boostcamp, select entrepreneurs will be chosen to participate in a Pitch Lab to present their business to a grant selection committee. Ultimately, 20 business owners will be selected and will each receive a $20,000 grant from BOTOX® Cosmetic to help make their business goals a reality. The selection panel is comprised of Allergan Aesthetics executives and aesthetic entrepreneurs, including Shawna Chrisman, Board-Certified Nurse Practitioner and Founder of Destination Aesthetics Medical Spa™; Nicci Levy, CEO and Founder of ALCHEMY 43; and Caroline Robinson, MD, FAAD, Board-Certified Dermatologist and Founder of Tone Dermatology."As a founder and entrepreneur, I know firsthand how critical community is when building a successful business. The opportunity to participate in The Confidence Project since the beginning has been deeply inspiring," said Shawna Chrisman. "These entrepreneurs aren't just growing companies; they're reshaping industries and bettering communities."The 20 grant recipients will be announced in October 2025. For more information on The Confidence Project, visit www.botoxcosmetic.com/realimpact and follow @botoxcosmetic on Instagram and YouTube where participants will be featured in the coming months.About Allergan Aesthetics At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.allerganaesthetics.com. About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube. Approved Uses BOTOX® Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe forehead lines, crow's feet lines, frown lines between the eyebrows, and vertical bands connecting the jaw and neck (platysma bands) in adults. IMPORTANT SAFETY INFORMATION BOTOX® Cosmetic may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX® Cosmetic:  Problems swallowing, speaking, or breathing, due to weakening of associated muscles, which can be severe and result in loss of life. You are at the highest risk if these problems are preexisting before injection. Swallowing problems may last for several months.  Spread of toxin effects. The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms, including loss of strength and all-over muscle weakness, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, and trouble swallowing.  BOTOX® Cosmetic dosing units are not the same as, or comparable to, any other botulinum toxin product. There has not been a confirmed serious case of spread of toxin effect when BOTOX® Cosmetic has been used at the recommended dose to treat frown lines, crow's feet lines, forehead lines, and/or platysma bands. BOTOX® Cosmetic may cause loss of strength or general muscle weakness, vision problems, or dizziness within hours to weeks of receiving BOTOX® Cosmetic. If this happens, do not drive a car, operate machinery, or do other dangerous activities. Serious and/or immediate allergic reactions have been reported, including itching, rash, red itchy welts, wheezing, asthma symptoms, or dizziness or feeling faint. Get medical help right away if you are wheezing or have asthma symptoms, or if you become dizzy or faint. Do not receive BOTOX® Cosmetic if you are allergic to any of the ingredients in BOTOX® Cosmetic (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc (rimabotulinumtoxinB), Dysport (abobotulinumtoxinA), Xeomin (incobotulinumtoxinA), Jeuveau (prabotulinumtoxinA-xvfs), Daxxify (daxibotulinumtoxinA-lanm), or Letybo (letibotulinumtoxinA-wlbg); or have a skin infection at the planned injection site. This list may not include all available botulinum toxin products. Tell your doctor about all your muscle or nerve conditions, such as ALS or Lou Gehrig's disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at increased risk of serious side effects, including difficulty swallowing and difficulty breathing, from standard doses of BOTOX® Cosmetic. Tell your doctor about all your medical conditions, including surgery or plans to have surgery on your face, trouble raising your eyebrows, drooping eyelids, any other abnormal facial change, are pregnant or plan to become pregnant (it is not known if BOTOX® Cosmetic can harm your unborn baby), or are breastfeeding or plan to (it is not known if BOTOX® Cosmetic passes into breast milk). Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX® Cosmetic with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received BOTOX® Cosmetic in the past. Tell your doctor if you have received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin such as Myobloc, Dysport, Xeomin, Jeuveau, Daxxify, or Letybo in the past (tell your doctor exactly which product you received); have recently received an antibiotic by injection; take muscle relaxants; take an allergy or cold medicine; take a sleep medicine; or take aspirin-like products or blood thinners. Other side effects of BOTOX® Cosmetic include dry mouth; discomfort or pain at the injection site; tiredness; headache; neck pain; and eye problems, including double vision, blurred vision, decreased eyesight, drooping eyelids and eyebrows, swelling of eyelids, and dry eyes. For more information, refer to the Medication Guide or talk with your doctor. To report a side effect, please call Allergan Aesthetics at 1-800-678-1605. Please see BOTOX® Cosmetic full Prescribing Information, including Boxed Warning and Medication Guide. © 2025 AbbVie. All rights reserved. BOTOX Cosmetic and its designs are trademarks of Allergan Holdings France SAS, an AbbVie company, or its affiliates. Contacts: Investors:Liz Shea [email protected] (847) 935-2211 Media: Ember Garrett [email protected] (714) 246-3525 SOURCE AbbVie WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News